Skip to Content

RP 200 (Fenofibrate (Micronized) 200 mg)

Pill with imprint RP 200 is Orange, Capsule-shape and has been identified as Fenofibrate (Micronized) 200 mg. It is supplied by Rhodes Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RP 200

Fenofibrate (Micronized)

Imprint:
RP 200
Strength:
200 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Rhodes Pharmaceuticals
Manufacturer:
Teva Canada Limited
National Drug Code (NDC):
42858-0200

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide